Literature DB >> 12399501

Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response.

Sean D Reid1, Nicole M Green, Gail L Sylva, Jovanka M Voyich, Elisha T Stenseth, Frank R DeLeo, Timothy Palzkill, Donald E Low, Harry R Hill, James M Musser.   

Abstract

Analysis of three group A Streptococcus genomes (serotypes M1, M3, and M18) recently identified four previously undescribed genes that encode extracellular proteins. Each of these genes encode proteins with an LPXTG amino acid motif that covalently links many virulence factors produced by gram-positive bacteria to the cell surface. Western immunoblot analysis of serum samples obtained from 80 patients with invasive infections, noninvasive soft tissue infections, pharyngitis, and rheumatic fever indicated that these four proteins are expressed in vivo. However, the level of gene transcript and the time of maximal gene transcription varied in representative serotype M1, M3, and M18 strains. Surface expression of two proteins was confirmed by flow cytometry. Studies using a mouse infection model suggest that antibodies specific for one of the proteins (Spy0843) may contribute to a protective host immune response against a serotype M1 infection. These results are additional evidence that postgenomic strategies provide new ways to identify and investigate novel bacterial proteins that may participate in host-pathogen interactions or serve as targets for therapeutics research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399501      PMCID: PMC151937          DOI: 10.1128/JB.184.22.6316-6324.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

Review 1.  Mining genomes and mapping proteomes: identification and characterization of protein subunit vaccines.

Authors:  D N Chakravarti; M J Fiske; L D Fletcher; R J Zagursky
Journal:  Dev Biol (Basel)       Date:  2000

Review 2.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.

Authors:  S D Reid; N P Hoe; L M Smoot; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates.

Authors:  D N Chakravarti; M J Fiske; L D Fletcher; R J Zagursky
Journal:  Vaccine       Date:  2000-11-08       Impact factor: 3.641

4.  Identification of Rgg-regulated exoproteins of Streptococcus pyogenes.

Authors:  M S Chaussee; R O Watson; J C Smoot; J M Musser
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

6.  Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach.

Authors:  G R Bolduc; V Bouchet; R Z Jiang; J Geisselsoder; Q C Truong-Bolduc; P A Rice; S I Pelton; R Goldstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen.

Authors:  S Lukomski; K Nakashima; I Abdi; V J Cipriano; R M Ireland; S D Reid; G G Adams; J M Musser
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Identification and immunogenicity of group A Streptococcus culture supernatant proteins.

Authors:  B Lei; S Mackie; S Lukomski; J M Musser
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.

Authors:  T M Wizemann; J H Heinrichs; J E Adamou; A L Erwin; C Kunsch; G H Choi; S C Barash; C A Rosen; H R Masure; E Tuomanen; A Gayle; Y A Brewah; W Walsh; P Barren; R Lathigra; M Hanson; S Langermann; S Johnson; S Koenig
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  The analysis of streptococcal infections. VI. Immunoelectrophoretic observations on extracellular antigens detectable with human antibodies.

Authors:  S P HALBERT; S L KEATINGE
Journal:  J Exp Med       Date:  1961-06-01       Impact factor: 14.307

View more
  27 in total

1.  Genetics of streptococci, lactococci, and enterococci: review of the sixth international conference.

Authors:  Janet Yother; Patrick Trieu-Cuot; Todd R Klaenhammer; Willem M De Vos
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

2.  Identification of srv, a PrfA-like regulator of group A streptococcus that influences virulence.

Authors:  Sean D Reid; Alison G Montgomery; James M Musser
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 3.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

4.  Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Authors:  Shizhen Zhang; Nicole M Green; Izabela Sitkiewicz; Rance B Lefebvre; James M Musser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Expression, purification and crystallization of the C-terminal LRR domain of Streptococcus pyogenes protein 0843.

Authors:  Teemu Haikarainen; Vuokko Loimaranta; Carlos Prieto-Lopez; Pradeep Battula; Jukka Finne; Anastassios C Papageorgiou
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-30

6.  Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.

Authors:  Yuanyi Li; Gabriela Martinez; Marcelo Gottschalk; Sonia Lacouture; Philip Willson; J Daniel Dubreuil; Mario Jacques; Josee Harel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Authors:  Subhashini Arimilli; Sharad K Sharma; Rama Yammani; Sean D Reid; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

8.  Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Authors:  Andrea Fritzer; Beatrice M Senn; Duc Bui Minh; Markus Hanner; Dieter Gelbmann; Birgit Noiges; Tamás Henics; Kai Schulze; Carlos A Guzman; John Goodacre; Alexander von Gabain; Eszter Nagy; Andreas L Meinke
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

9.  Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection.

Authors:  Morag R Graham; Kimmo Virtaneva; Stephen F Porcella; Donald J Gardner; R Daniel Long; Diane M Welty; William T Barry; Claire A Johnson; Larye D Parkins; Fred A Wright; James M Musser
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

10.  Allelic replacement of the streptococcal cysteine protease SpeB in a Δsrv mutant background restores biofilm formation.

Authors:  Amity L Roberts; Robert C Holder; Sean D Reid
Journal:  BMC Res Notes       Date:  2010-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.